PACB Pacific Biosciences of California
Company Analysis
Latest News
🔴 Pacific Biosciences is trading 10.2% down with no identified company catalyst
Pacific Biosciences is trading 10.2% down now at $1.76, with no clear company-specific announcement explaining the October 16 drop. - MarketWatch also...
🔴 Pacific Biosciences is trading 7% down today amid biotech sector weakness
Pacific Biosciences is trading 7.4% down at $1.81, alongside weakness across the biotech sector. - Biotech ETF XBI is down 2.06% during the regular session. -...
🔴 Pacific Biosciences is trading 10.1% down with no confirmed catalyst identified
Pacific Biosciences is trading 10.1% down at $2.10 on October 12, 2026, with no confirmed company-specific catalyst identified. - The latest company...
🔴 Pacific Biosciences is trading 6.4% down with no confirmed catalyst
Pacific Biosciences is trading 6.4% lower at $2.18, with no confirmed catalyst identified for the October 12 decline. - Latest company news located was an...
🟢 Pacific Biosciences is trading 6.1% up
Pacific Biosciences is trading 6.1% up at $2.44 on October 9, recovering from its October 8 close of $2.30, which was down 15.44%. - No new company-specific...
🔴 Pacific Biosciences is trading 11.73% down today amid biotech weakness and rising oil prices
Pacific Biosciences is trading 11.73% lower at $2.40 as biotech shares weaken and oil prices rise, though no company-specific cause for the October 8 decline...
🔴 Pacific Biosciences is trading 6% down today amid rising oil prices and elevated Treasury yields
Pacific Biosciences is trading at $2.56, down 5.88%, with broader market pressure potentially contributing to the decline. - No new company-specific...
🔴 Pacific Biosciences is trading 5.4% down
Pacific Biosciences is trading 5.37% down at $2.58 on October 7, 2026; no new company-specific catalyst was identified. - October 6 TychoBio collaboration...
PacBio Teams With TychoBio to Train RNA-Therapy AI on 10,000+ Samples
Pacific Biosciences of California (PacBio) announced a collaboration with AI drug discovery company TychoBio to advance RNA therapies for rare diseases....
🔴 Pacific Biosciences is trading 6.3% down in pre-market amid a pullback after recent gains
Pacific Biosciences is trading 6.3% down in pre-market at $2.53 on October 7, amid a pullback after a recent rally. - Shares climbed from $1.71 on September...
🔴 Pacific Biosciences is trading 10.98% down today with biotech-sector weakness a likely factor
Pacific Biosciences is trading 10.98% lower at $2.56, with biotech-sector weakness a likely contributor but no clear company-specific negative catalyst...
🔴 Pacific Biosciences is trading 6.7% down today amid biotech-sector weakness
Pacific Biosciences is trading at $2.68, down 6.69%, with biotech-sector weakness a possible contributor. - The XBI is down 2.50%, while major U.S. indices...
PacBio Rides a Rare-Disease Partnership Wave to New Highs — But Can a Sub-$900M Company Turn Ecosystem Wins Into Revenue?
Shares shifted sharply as Pacific Biosciences (PACB) extended a blistering October rally, trading at $3.07 — up 7% on the day and 68% from just a week ago at...
🟢 Pacific Biosciences is trading 16% up today after EpiSign-Geneyx rare-disease partnership
Pacific Biosciences is trading 16.20% higher at $3.33 following news of an EpiSign and Geneyx partnership to bring PacBio HiFi sequencing data into...
🟢 Pacific Biosciences is trading 7% up today after EpiSign–Geneyx rare-disease partnership
Pacific Biosciences is trading at $3.07, up +7.04%, as an EpiSign–Geneyx partnership uses PacBio HiFi data for rare-disease interpretation. - The agreement...
🟢 Pacific Biosciences is trading 10% up today amid broader-market gains
Pacific Biosciences is trading at $2.79, up +10.04%, amid broader-market support; no clear new company-specific trigger was identified. - Its press-release...
🟢 Pacific Biosciences is trading 5% up
Pacific Biosciences is trading at $2.67, up 5.12% on October 5, 2026, with no clear company-specific catalyst identified. - The October 1 surge was attributed...
🟢 Pacific Biosciences is trading 5% up; no clear catalyst identified
Pacific Biosciences is trading 5.27% up at $2.50 on October 1, extending a multi-session rally with no clearly established catalyst for the latest increase. -...
🟢 Pacific Biosciences is trading 12.57% up — no clear September 30 catalyst identified
Pacific Biosciences is trading at $2.06, up 12.57%, with no clear September 30 catalyst identified. - A contemporaneous market report also described the move...
🟢 Pacific Biosciences is trading 7.65% up; no September 30 catalyst identified
Pacific Biosciences is trading up 7.65% at $1.97 on September 30, 2026; no new company announcement or clear catalyst specific to the session was...